Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection.

The Medical clinics of North America - 1 Jul 2017

Barry Michael J, Simmons Leigh H

Abstract excerpt

More than any other cancer, prostate cancer screening with the prostate-specific antigen (PSA) tests increases the risk a man will have to face a diagnosis of prostate cancer. The best evidence from screening trials suggests a small but finite benefit from prostate cancer screening in terms of prostate cancer-specific mortality, about 1 fewer prostate cancer death per 1000 men screened over 10 years. The more...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Diet
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Life Style

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Share to Racial Groups

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 28577627
DOI: 10.1016/j.mcna.2017.03.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection.PMID 28577627Read ↗

Risk factors, prevention and early detection of prostate cancer.Semantic proximity Read ↗

Precision intervention for prostate cancer: Re-evaluating who is at risk.Semantic proximity Read ↗

Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents.Semantic proximity Read ↗

[Epidemiological fundamentals of clinically localized prostate cancer].Semantic proximity Read ↗

The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment.Semantic proximity Read ↗

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.Semantic proximity Read ↗

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.Semantic proximity Read ↗

The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriers.Semantic proximity Read ↗

Diagnosis, staging, and risk stratification in prostate cancer: Utilizing diagnostic tools to avoid unnecessary therapies and side effects.Semantic proximity Read ↗

Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms.Semantic proximity Read ↗

Risk of Secondary Malignancies in Patients with prostate cancer: A Systematic Review and Meta-analysisSemantic proximity Read ↗

A review of targeted screening for prostate cancer: introducing the IMPACT study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.